Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
About this study
The study is a retrospective observational study. The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic, VATS and open approach after receiving neoadjuvant chemo-immunotherapy. There are no risks for the patients, as this is a retrospective data collection.
- Condition
- Non-Small Cell Lung Cancer
- Sponsor
- Scientific Institute San Raffaele
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 5
- Minimum age: 18 years
- Study condition: Non-Small Cell Lung Cancer
- Diagnosis of clinical or pathological stage IIB (T1-2, hilar N1, M0) and III (any T, N1-2, M0) NSCLC surgically treated with robotic, VATS and open approach with radical intent from 1st of January 2016 to 31st of March 2024
- Received neoadjuvant chemo-immunotherapy or immunotherapy alone
- Age \>= 18 years old at the moment of surgery
Exclusion 1
- Age \<18 years old at the moment of surgery
Where
6 sites, 6 recruiting
Scientific Institute Ospedale San Raffaele
Milan, Italy
Regina Elena National Cancer Institute
Rome, Italy
Istituto Clinico Humanitas
Rozzano, Milan, Italy
Baptist Health South Florida
Miami, Florida, United States
West Virginia University
Morgantown, West Virginia, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Contact
-
Pierluigi Novellis, Medical Doctor
0226437202 novellis.pierluigi@hsr.it
Potential match only. Final eligibility is determined by the study team.